Keiko Mizuno

7PUBLICATIONS
11CO-AUTHORS
Molecular targetsMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 26, 2026
AKT Inhibitor Capivasertib as a Target for Osimertinib Combination Therapy in Lung Adenocarcinoma with EGFR Mutation.

|Jul 28, 2026
The microRNA Expression Signature of Lung Adenocarcinoma Harboring EGFR Mutations: Identification of Therapeutic Targets for EGFR-TKI Combination Therapy.

|Jul 29, 2025
MicroRNA Signatures in Lung Adenocarcinoma Metastases: Exploring the Oncogenic Targets of Tumor-Suppressive miR-195-5p and miR-195-3p.

Yuya Tomioka, Naohiko Seki, Keiko Mizuno

|Aug 08, 2018
Dual strands of the miR-145 duplex (miR-145-5p and miR-145-3p) regulate oncogenes in lung adenocarcinoma pathogenesis.

Shunsuke Misono, Naohiko Seki, Keiko Mizuno

|Mar 10, 2017
The microRNA expression signature of small cell lung cancer: tumor suppressors of miR-27a-5p and miR-34b-3p and their targeted oncogenes.

Keiko Mizuno, Hiroko Mataki, Takayuki Arai

|Aug 05, 2016
MicroRNAs in non-small cell lung cancer and idiopathic pulmonary fibrosis.

Keiko Mizuno, Hiroko Mataki, Naohiko Seki

Pageof 2

Frequent Collaborators

4 joint publications

Hiromasa Inoue

3 joint publications

Yuya Tomioka

3 joint publications

Naohiko Seki

2 joint publications

Takuya Tokunaga